Literature DB >> 24862675

Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.

Giovanni Conzo1, Claudio Mauriello2, Giovanni Docimo2, Claudio Gambardella2, Guglielmo Thomas2, Fabio Cavallo2, Ernesto Tartaglia2, Salvatore Napolitano2, Roerto Varriale2, Gianluca Rossetti2, Landino Fei2, Luigi Santini2.   

Abstract

INTRODUCTION: Lymph nodal involvement in papillary thyroid cancers is very common, but the role of lymph node dissection is still controversial. Surgeons are consequently divided between opposed to and in favor of routine central neck dissection associated with total thyroidectomy.
METHODS: Clinical records of 210 patients undergoing from January 2000 to December 2006 total thyroidectomy without routine lymph node dissection were retrospectively evaluated. One hundred and ninety eight patients (94.2%) underwent radioiodine ablation as well, followed by Thyroid Stimulating Hormone suppression therapy. In patients with loco regional lymph nodal recurrence, central (VI) and ipsilateral (III-IV) lymph node dissection was performed.
RESULTS: Incidence of permanent hypoparathyroidism (iPTH < 10 pg/ml) and permanent vocal fold paralysis were respectively 1.4% and 1.9%. After an 8-year mean follow-up, the rate of loco regional recurrence was 4.2%-9/210 patients. In these cases selective lymph node dissection was carried out without complications. DISCUSSION: The role of neck dissection in papillary thyroid cancer management, is still subject of research and controversial regarding routine or therapeutic indications, surgical extension, its impact on local recurrence and survival.
CONCLUSION: A low loco regional recurrence rate may be observed after total thyroidectomy without prophylactic lymph node dissection. Lymph nodal recurrences were more frequent in young male patients, sometime affected by follicular variant, in each case less than 2 cm. There is a general agreement about the extension of therapeutic lymph node dissection, while routine central neck dissection is still controversial and may be indicated in high risk patients.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Lymph node neck dissection; Lymph node recurrence; Papillary thyroid cancer; Radioactive iodine ablation; Routine central lymph node dissection; Total thyroidectomy

Mesh:

Year:  2014        PMID: 24862675     DOI: 10.1016/j.ijsu.2014.05.010

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  18 in total

1.  Nomograms based on preoperative multimodal ultrasound of papillary thyroid carcinoma for predicting central lymph node metastasis.

Authors:  Quan Dai; Dongmei Liu; Yi Tao; Chao Ding; Shouqiang Li; Chen Zhao; Zhuo Wang; Yangyang Tao; Jiawei Tian; Xiaoping Leng
Journal:  Eur Radiol       Date:  2022-02-28       Impact factor: 5.315

2.  Recurrent Papillary Thyroid Carcinoma to the Cervical Lymph Nodes: Outcomes of Compartment-Oriented Lymph Node Resection.

Authors:  Carlos Gustavo Rivera-Robledo; David Velázquez-Fernández; Juan Pablo Pantoja; Mauricio Sierra; Bernardo Pérez-Enriquez; Raul Rivera-Moscoso; Mónica Chapa; Miguel F Herrera
Journal:  World J Surg       Date:  2019-11       Impact factor: 3.352

3.  Relationship between lymphovascular invasion and clinicopathological features of papillary thyroid carcinoma.

Authors:  Atakan Sezer; Mehmet Celik; Buket Yilmaz Bulbul; Nuray Can; Ebru Tastekin; Semra Ayturk; Funda Ustun; Sibel Guldiken; Necdet Sut
Journal:  Bosn J Basic Med Sci       Date:  2017-05-20       Impact factor: 3.363

4.  Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis.

Authors:  Jae-Gu Cho; Hyung Kwon Byeon; Kyung Ho Oh; Seung-Kuk Baek; Soon-Young Kwon; Kwang-Yoon Jung; Jeong-Soo Woo
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-17       Impact factor: 2.503

5.  The relevance of preoperative ultrasound cervical mapping in patients with thyroid cancer.

Authors:  Davit Kocharyan; Frank Schwenter; Manon Bélair; Edgard Nassif
Journal:  Can J Surg       Date:  2016-04       Impact factor: 2.089

Review 6.  Surgical aspects and controversies in the management of medullary thyroid cancer.

Authors:  Katerina Green; Justin Hintze; James Paul O'Neill
Journal:  Ir J Med Sci       Date:  2022-01-22       Impact factor: 1.568

Review 7.  Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.

Authors:  Claudio Gambardella; Ernesto Tartaglia; Anna Nunziata; Graziella Izzo; Giuseppe Siciliano; Fabio Cavallo; Claudio Mauriello; Salvatore Napolitano; Guglielmo Thomas; Domenico Testa; Gianluca Rossetti; Alessandro Sanguinetti; Nicola Avenia; Giovanni Conzo
Journal:  World J Surg Oncol       Date:  2016-09-19       Impact factor: 2.754

8.  Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer.

Authors:  Yinghao Wang; Yixiang Jin; Adheesh Bhandari; Zhihan Yao; Fan Yang; Yiyuan Pan; Zhouci Zheng; Shixu Lv; Ouchen Wang
Journal:  Onco Targets Ther       Date:  2017-12-21       Impact factor: 4.147

9.  Prognostic value of long non-coding RNA BLACAT1 in patients with papillary thyroid carcinoma.

Authors:  Denghui Liao; Gang Lv; Ting Wang; Jie Min; Yadong Wang; Shengchun Liu
Journal:  Cancer Cell Int       Date:  2018-03-27       Impact factor: 5.722

10.  A Study on Central Lymph Node Metastasis in 543 cN0 Papillary Thyroid Carcinoma Patients.

Authors:  Huanhuan Yan; Xiaoqian Zhou; Hui Jin; Xiang Li; Miao Zheng; Xu Ming; Ruitao Wang; Jun Liu
Journal:  Int J Endocrinol       Date:  2016-04-03       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.